Survival Risk Prediction Models of Glioma Based on IDH and 1 p/19q

被引:0
|
作者
Zou, Han [1 ,2 ]
Wanggou, Siyi [2 ]
Lie, Xuejun [2 ]
机构
[1] Cent S Univ, Xiangya Med Sch, Dept Xiangya, 172 Tongzipo Rd, Changsha 410006, Hunan, Peoples R China
[2] Cent S Univ, Xiangya Hosp, Dept Neurosurg, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China
来源
JOURNAL OF CANCER | 2019年 / 10卷 / 23期
关键词
survival analysis; prediction model; ncRNA; molecular features; glioma; NONCODING RNA; GLIOBLASTOMA; CLASSIFICATION; DISULFIRAM; COPPER; ROLES;
D O I
10.7150/jca.31063
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To explore the prognostic factors of 3 kinds of gliomas based on molecular features (IDH and 1p/19q), we performed a univariate survival analysis on the RNA-seq data of 653 patients in The Cancer Genome Atlas. Separately, 12205 (20.18%), 6125 (10.13%) and 5206 (8.61%) genes were associated with the overall survival (OS) of the IDH-wildtype, IDH-mutation 1p/19q intact and IDH-mutation 1p/19q codeletion. With these OS related genes, the pathway enrichment revealed that alcoholism, systemic lupus erythematosus, hematopoietic cell lineage and diabetes might affect the OS of glioma patients. Besides, the more OS related genes a glioma had, the poorer prognosis it would be. With the selected genes, we used Lasso regression to set up three models that can effectively predict the survival risk of each type. Totally, the three models contain 76 genes expression level. Moreover, none of the 76 genes was repeated in another model, which suggested the enormous difference among the three subtypes. SERPINA5, RP11.229A12.2 and RP11.62F24.2 were in common among model containing genes of one subtype and OS related genes of other two subtypes. Besides, five genes' (RP11.229A12.2, RP11.62F24.2, C3orf67, RP11.275H4.1 and TBX3) function (protection or risk factor) opposed in different subtypes. More attention, non-coding RNA plays a vital important role in the prognosis of glioma (58.74%, 70.13% and 58.11% in the IDH-wildtype, IDH-mutation 1p/19q intact and IDH-mutation 1p/19q codeletion). What's more, after multivariate adjustment by Cox regression, prognostic value of the models maintained powerful and independent of clinicopathological features. In conclusion, the multi-gene-based classifiers add great prognostic value to the current stage system, and the RNAs and their related genes deserve further study for their mechanisms in influencing the OS and their clinical significance in improving the OS.
引用
收藏
页码:5832 / 5842
页数:11
相关论文
共 50 条
  • [1] Survival Risk Prediction Models of Gliomas Based on IDH and 1p/19q
    Zou, Han
    Li, Chang
    Wanggou, Siyi
    Li, Xuejun
    JOURNAL OF CANCER, 2020, 11 (15): : 4297 - 4307
  • [2] Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
    Eckel-Passow, Jeanette E.
    Lachance, Daniel H.
    Molinaro, Annette M.
    Walsh, Kyle M.
    Decker, Paul A.
    Sicotte, Hugues
    Pekmezci, Melike
    Rice, Terri
    Kosel, Matt L.
    Smirnov, Ivan V.
    Sarkar, Gobinda
    Caron, Alissa A.
    Kollmeyer, Thomas M.
    Praska, Corinne E.
    Chada, Anisha R.
    Halder, Chandralekha
    Hansen, Helen M.
    Mccoy, Lucie S.
    Bracci, Paige M.
    Marshall, Roxanne
    Zheng, Shichun
    Reis, Gerald F.
    Pico, Alexander R.
    O'Neill, Brian P.
    Buckner, Jan C.
    Giannini, Caterina
    Huse, Jason T.
    Perry, Arie
    Tihan, Tarik
    Berger, Mitchell S.
    Chang, Susan M.
    Prados, Michael D.
    Wiemels, Joseph
    Wiencke, John K.
    Wrensch, Margaret R.
    Jenkins, Robert B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26): : 2499 - 2508
  • [3] Loss of heterozygosity 1p/19q and survival in glioma: a meta-analysis
    Zhao, Jiaxin
    Ma, Wenjie
    Zhao, Hong
    NEURO-ONCOLOGY, 2014, 16 (01) : 103 - 112
  • [4] IDH1 MUTATIONS WITH RELEVANCE TO 1P/19Q LOSS AND MGMT METHYLATION IN PEDIATRIC GLIOMA PATIENTS
    Adachi, J.
    Suzuki, T.
    Yanagisawa, T.
    Mishima, K.
    Fukuoka, K.
    Koga, T.
    Matsutani, M.
    Nishikawa, R.
    NEURO-ONCOLOGY, 2012, 14 : 66 - 66
  • [5] Radiomics-Based Method for Predicting the Glioma Subtype as Defined by Tumor Grade, IDH Mutation, and 1p/19q Codeletion
    Li, Yingping
    Ammari, Samy
    Lawrance, Littisha
    Quillent, Arnaud
    Assi, Tarek
    Lassau, Nathalie
    Chouzenoux, Emilie
    CANCERS, 2022, 14 (07)
  • [6] Arterial spin Labeling for Glioma Grade Discrimination: Correlations with IDH1 Genotype and 1p/19q Status
    Wang, Ning
    Xie, Shu-yi
    Liu, Hui-ming
    Chen, Guo-quan
    Zhang, Wei-dong
    TRANSLATIONAL ONCOLOGY, 2019, 12 (05): : 749 - 756
  • [7] HIP1R and Vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma
    Felix, Marius
    Friedel, Dennis
    Jayavelu, Ashok Kumar
    Filipski, Katharina
    Reinhardt, Annekathrin
    Warnken, Uwe
    Stichel, Damian
    Schrimpf, Daniel
    Korshunov, Andrey
    Wang, Yueting
    Kessler, Tobias
    Etminan, Nima
    Unterberg, Andreas
    Herold-Mende, Christel
    Heikaus, Laura
    Sahm, Felix
    Wick, Wolfgang
    Harter, Patrick N.
    von Deimling, Andreas
    Reuss, David E.
    NEURO-ONCOLOGY, 2022, 24 (12) : 2121 - 2132
  • [8] Cyclin pathway in oligodendrogliomas IDH mut and 1p/19q codeleted
    Salgado, M. A. Vaz
    Sanchez, J. M. Sepulveda
    Earl, J.
    Perez, A.
    Pian, H.
    Ruano, Y.
    Gutierrez, J.
    Mena, A. Carrato
    Ley, L. L.
    Villamayor, M.
    Lopez, V.
    Delfrade, I. Martinez
    Albarran, V.
    Chamorro-Perez, J.
    Rodriguez, D. I. Rosero
    Moron, B. I.
    Lain, A. H.
    ANNALS OF ONCOLOGY, 2023, 34 : S397 - S397
  • [9] Primary gliosarcoma with IDH1 mutation and codeletion of 1p and 19q
    Lee, H. -Y.
    Ding, C. S. -Lyn
    Chilagondanahalli, N. L.
    Ho, B. C. -Shern
    Ho, Y. -H.
    Chuah, K. -L.
    VIRCHOWS ARCHIV, 2018, 473 : S27 - S27
  • [10] IDH Mutations, MGMT Methylation and 1p/19q Status Provides Better Diagnosis and Survival Prediction in an Indian Cohort of Diffuse Gliomas
    Majumdar, A.
    Katara, R.
    Bhardwaj, M.
    Verma, A.
    Sharma, D. K.
    Kumar, S.
    Kini, L.
    Pandita, A.
    Singh, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1188 - 1188